Osteopore (ASX:OSX) has announced a number of milestones it believes will increase its presence and commercial opportunities across South East Asia.

Osteopore implants received regulatory approval from the Indonesian Ministry of Health for dental applications, which is a growing market worth an estimated US$4B by 2026.

It also signed an exclusive distribution agreement with Avero to promote and sell the company?s oral and maxillofacial products within Malaysia.

Osteopore?s share price is up 33% the past 6 months.